Issuer transition strips SNC to a $2.1m acquisition shell

Total assets fell from NZ$2.2b to NZ$2.1m, cash from NZ$2.2b to NZ$44k, and total equity from NZ$2.1b to NZ$2.0m. Revenue, now consisting only of interest income, fell -100.0% from NZ$18.2m to NZ$4,016. The headline +99.8% improvement in both PBT and NPAT (from -NZ$59.2m to -NZ$0.1m) is the arithmetic of an entity that no longer carries the prior operating base.

Operating cash outflow narrowed to -NZ$0.1m from -NZ$71.6m. Total assets at NZ$2.1m sit above Annolyse's historical baseline range of NZ$0.3m-NZ$1.9m (mean NZ$1.0m), which is consistent with HY22 being the opening balance for the shell.

Event overlays flag a current issuer transition and acquisition activity in both periods. The HY21 numbers belong to a fundamentally different entity carrying NZ$2.2bn of assets and NZ$83.5m of liabilities. Reading +99.8% PBT growth as operating improvement would be incorrect — the loss narrowed only because the loss-generating operations are gone.

The company is now a shell hunting acquisitions with minimal liquidity. With NZ$44k of cash against NZ$2.0m of equity, any sizeable acquisition will need fresh capital or majority-shareholder underwrite. The release states the Company "continues to look for appropriate acquisition targets with the support of the majority" shareholder, which means the equity story is dependent on a transaction that has not been announced.

The income statement is now almost entirely cost. Interest income of NZ$4,016 against a NZ$107,388 loss implies recurring shell overhead of roughly NZ$0.1m per half. At the current cash balance this is well under one period of runway without intervention.

Stated outlook is acquisition-driven and qualitative. The supplied second-half shape (HY21 contributed 72.1% of FY21 revenue and 50.3% of FY21 NPAT) relates to the prior issuer and provides no signal for the current shell, so neither a run-rate nor a seasonality read is available.

What this release supports is a corporate-action waiting brief: value depends entirely on which target is acquired and on what terms. What it does not support is any operating-performance read or extrapolation from the headline percentage moves.

PBT growth of +99.8% (and identical NPAT growth, given a 0.0% effective tax rate in both periods) carries no read-through to future earnings power. Because PBT and NPAT move together, there is no tax distortion to disentangle; the cleaner read is simply that there is little operating substance to evaluate.

Cash conversion deteriorated on the supplied metric basis, but the comparison is distorted by the transition rather than informative. The more useful observation is that the entity now sits on a small equity base with no operating revenue and ongoing shell overhead. ROE of -5.4% versus -2.8% prior is a function of equity shrinking by more than the loss, not an operating signal.

This briefing cannot assess the identity, valuation, or terms of any prospective acquisition, nor the depth of the majority shareholder's support beyond the brief outlook statement supplied.